Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-01, Stock:ABBV, The news for the past five days is as follows:
2020-08-25: NEWS1: Do AbbVie's (NYSE:ABBV) Earnings Warrant Your Attention?.NEWS2: AbbVie Submits Regulatory Application to FDA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Ankylosing Spondylitis.NEWS3: The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout.NEWS4: AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases.NEWS5: Morphic Announces that AbbVie Exercises License Option to αvβ6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases.
2020-08-26: NEWS1: Could This Options Trade In AbbVie Generate A 93% Return By September?.NEWS2: AbbVie Seeks FDA Approval for Rinvoq in Ankylosing Spondylitis.NEWS3: Hedge Funds Have Never Been This Bullish On AbbVie (ABBV).NEWS4: AbbVie vs Biogen: Which Drugmaker Scores A ‘Strong Buy’ Street Consensus?.
2020-08-27: nan
2020-08-28: NEWS1: These 3 Dividend Stocks Could Bring You an Extra $100 a Month.
2020-08-31: NEWS1: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.NEWS2: Pharma Stock Roundup: AZN's Coronavirus Antibody Combo Study, & Other Updates.

Answer: Decrease